Tus kws kho mob
QP17-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Droxia and Siklos®
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 24, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1691 - 1700 ntawm 4303
Tus kws kho mob
QP18-21 Blue Cross to Collaborate with VillageHealth
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 24, 2021
Tus kws kho mob
2021 March Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 24, 2021
Kev Yuav Khoom thiab Kev Kawm Paub
Gender Care and Service
Tus kws kho mob
BCBSMN-Upcoming-Pharm-Policy-Notif-040121.pdf
Tus kws kho mob
QP16-21 Overpayment Refund/Recoupment Notification Process for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 10, 2021
Tus kws kho mob
QP15-21 Provider Fee Schedule Request
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 10, 2021
Tus kws kho mob
QP14-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Enspryng™(satralizumab-mwge) PAQL
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 10, 2021
Tus kws kho mob
QP13-21 Commercial and MHCP Pharmacy Benefit Exclusion for Cabenuva
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 10, 2021